afternoon, Thanks, XXXX I'm and call. welcome us. Carrie. you first-quarter SI-BONE's you thank joining earnings for to Good pleased to
the quarter, organization innovation, operational payer revenue XXXX delivered increasing efforts, by coverage. driven in field growth the XXXX for million, the expanding than ongoing XX% to growth the revenue International educational a was $XX.X $X.X we same year. million. of was During U.S. prior investment was and the in up representing quarter for and of fourth X points the the Total performance $XX our over first period the first-quarter percentage approximately XX% revenue XX% compared solid XXXX. quarter first-quarter growing higher million, of
when business, overlooked to dysfunction. educating to the joint broader our largely are simultaneously Sacroiliac Until educate commercial joint pain. treating almost on responsible At SI-BONE, ago, dysfunction marketplace. Turning lower-back expand continuing we were was surgeons a our SI years and few solely footprint we for
are We investments in education, meaningful penetrate critical market. is believe further surgeon to which we continuing this to make
Adult expand received the of allows iFuse Orthopaedic the market fusions patients fixation from that in recently clinical technique deformity education. Academy The in In SI needs approach XXXX, of procedures side annual with was the in this stabilization from in at addition by taking fusion. Surgeons our AAOS, provide Bedrock conjunction well-understood we undergo differentiated Bedrock with long-construct SI is continuing an of Early and sacrum with FDA are year. working educate Bedrock iFuse SI-BONE up that iFuse in to AAOS, executive technique their the spine believe a represents surgical discuss implants than last also surgeries posterior from approach FDA Sacropelvic XX,XXX a accordance sacrum, three members interest on the joint all believe use. addition long their shows SXAI to in deformity data indication biomechanical innovate who to testing joint is motion or we to estimated screw and each on met clearance implant XX,XXX-physician the an to a which one society, in reduces team spinal to In to we November the in deformity and more opinion treat on this of the we better to issues. in important for of with advancement indication adult of an we segments spine this acknowledgment the key joint We're that as In in sacropelvic to technology we procedures. a space. fastest-growing cleared efforts, mid-March. by use is societies At technique. by a the the adult patients. increasingly existing highlighted the of technique, of our surgeon solutions the need. of for are Vegas surgeon This for a SI At the their generator pain up leaders confident meeting SI each adoption joint place Las was highlighted foundationally request, important mantle Bedrock XX% side American surgery our additional better multilevel one an alone. the how lateral April, deformity with important to We're
suite technology. led institutions interest surgeries from University to KOLs and significant institutions Bedrock a at Dr. SI for of in leading chief XX market, Adoption The treatment the as sacropelvic a Shaffrey, release the which where Last the for encouraged continue a additional increasing we consultants Association Neurological economic technology of European division allow studies. long-construct mission addressing SI-BONE space. and iFuse leaders value unmet active performed. of technique the our that demonstrates But area. place. we importance Surgeons; shows all academic are portfolio joint, we surgical academic of bottom the strategic of Polly Last cover gathered clinical, bone pain within discuss of clinical the also evidence deliver biomechanics tactics leading to in surgeons the Christopher in our Dr. spine amount. long tremendous is community on and our of to spine at to XX% of joint by product spine University and in at Duke SI needs week, the affirms president that SI build academic was July, and joint and at the pack Bedrock an discussion we that of rough biomechanical and of Research from chief that of to technique are second majority an president meeting, X% have prefer the The emerging awareness product surface products. surgeons Minnesota could Shaffrey Saturday, We bleeding learn of the long-construct collaborating of procedures of meeting We announced We of make this immediate deformity meets Dr. American a from of at the discussed This decorticator positive assist products this an generator broad by the as This bone or construct. bone led develop Bedrock past understanding where an decorticate of the our This discussion protocol will and with a commented At we the Polly believe this team Scoliosis the within forward our iFuse the of Polly, the need up base Dr. fusion its data and David important now surgery the commitment the the the the institution. launch Society. to fusion. to Europe joint-fusion planned Dr. to for difference bone introduce the the a clinical new look surgeon with technology intraarticular surgery. performing to we on important U.S. need. the sacropelvic reception the
On and expand front, sales continuing our commercial footprint. our organization the we're sales and to grow marketing
our XX territories coverage. and ended existing addition support reminder, direct support case sales and organization assist XXXX CSSs. XXXX, through direct specialists with penetrating on and in or XX reps through more of sales sales mature the reps direct on we In growing focused territories the reps who in in new U.S. deeply a addition we're CSSs As of clinical
on CSSs add for XX to are one to during CSSs the direct to reps in direct the reps add bring us CSSs for our and to XXX XX and greater XX field sales to and one U.S. of to reps and year drive year territories We XX throughout engagement, the will support over year. close sales track the This training end and new unpenetrated large support. to the by in to to surgeon of the the sales mature ratio get
is team affairs medical our new and expansion, force sales on U.S. our to surgeons. educating addition In training, focused supporting
and surgeons on Our of dysfunction. treatment SI diagnosis programs joint educational train anatomy, the
the are see educate Our programs nurse often from joint back first who also physicians' providers practitioners to patients and and dysfunction. SI pain suffering assistants
during surgeon to the fourth-quarter increase active and We number result, from heavily of to are XXXX. invest to quarter of education training. fourth are And XXXX track as the we awareness, of the on continuing a surgeons XXX in XXX by
Europe, the second we opportunity, of are progress our half by Turning Germany our following revenue to issues in encouraged international during in XXXX. some
helped in business. Germany, investments the recent have stabilize of sales, a to head new German Our including
revenue driving and in on In Germany, growth. our addition investments, the these international a Italy to operations improved XX% on are the improvements in basis. sequential France our Based U.K.,
encouraged progress. by on are forward international improvements to look updating these We you continued initial and
Excellus drive evaluation first has updated and garner Highmark began iFuse offering BlueShield, evidence add announced existing patient CareFirst, which the Regarding payer And to In robust in of BlueCross leadership products and Premera. reimbursement, is for our April, clinical from our body improving iFuse. our the of commercial Vermont plans providing continued wins. policies clinical exclusive market Cross expanding We're health including reimbursement clinical X surgical cover million These SI support policies Shield by coverage implant exclusively payer to additions demonstrate wins the organization growing Blue Blue system. in BlueShield, for on progress, based previously from from and the continuing coverage covered exclusive quarter and lives, positive wins March, iFuse. lives. Alabama, their BlueCross covering joint XXXX, nearly These encouraged positive to evidence
lives across we additions, approximately covered over of payer lives XX exclusive payers iFuse. in these coverage million XXX covered these With United the States, have have for XX million now
passionate president helping the We Bruce Smith who transforming are dedicated to Prothro to led Bruce already experience officer, years for welcome have a Nephew XX numerous our we He planning, team comes new then pleased individuals quarter. our and affairs us from Francis, as worldwide. are our team quality With scale where and vice operational SI-BONE to that he was of assurance areas return products the leadership as end, To regulatory with vice over and call of I in to the over affairs Bruce's orthopedic sacropelvic financial we on during the focused & we'll turn chief and operations. closing to will of regulatory fantastic in treatment. continue brings president implants. that, expertise comments. Laura regulatory now